Considering m-Ino’s association with oncogenic PI3K pathways and as a proposed cancer inhibitor in human lung cancer48, our m-Ino results may indicate its function as an Hb tissue defense response in cancerous prostates, one providing endogenous tumor suppression of aggressive prostate cancer growth. The gene discussed is GSTM1; the disease is cancer.